FR2372841B1 - - Google Patents

Info

Publication number
FR2372841B1
FR2372841B1 FR7736336A FR7736336A FR2372841B1 FR 2372841 B1 FR2372841 B1 FR 2372841B1 FR 7736336 A FR7736336 A FR 7736336A FR 7736336 A FR7736336 A FR 7736336A FR 2372841 B1 FR2372841 B1 FR 2372841B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7736336A
Other languages
French (fr)
Other versions
FR2372841A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COVAL MYER
Original Assignee
COVAL MYER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COVAL MYER filed Critical COVAL MYER
Publication of FR2372841A1 publication Critical patent/FR2372841A1/fr
Application granted granted Critical
Publication of FR2372841B1 publication Critical patent/FR2372841B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/85Reproductive organs or embryos
    • Y10S530/851Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR7736336A 1976-12-03 1977-12-02 Gamma-globuline injectable par voie intraveineuse Granted FR2372841A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/747,063 US4124576A (en) 1976-12-03 1976-12-03 Method of producing intravenously injectable gamma globulin
KR7702742A KR810001001B1 (ko) 1976-12-03 1977-11-25 정맥 주사용 감마 글로부린의 제조방법

Publications (2)

Publication Number Publication Date
FR2372841A1 FR2372841A1 (fr) 1978-06-30
FR2372841B1 true FR2372841B1 (US20110009641A1-20110113-C00185.png) 1981-07-10

Family

ID=26626069

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736336A Granted FR2372841A1 (fr) 1976-12-03 1977-12-02 Gamma-globuline injectable par voie intraveineuse

Country Status (25)

Country Link
US (1) US4124576A (US20110009641A1-20110113-C00185.png)
JP (1) JPS6016407B2 (US20110009641A1-20110113-C00185.png)
KR (1) KR810001001B1 (US20110009641A1-20110113-C00185.png)
AR (1) AR215037A1 (US20110009641A1-20110113-C00185.png)
AT (1) AT361119B (US20110009641A1-20110113-C00185.png)
AU (1) AU516176B2 (US20110009641A1-20110113-C00185.png)
BE (1) BE861463A (US20110009641A1-20110113-C00185.png)
CA (1) CA1100872A (US20110009641A1-20110113-C00185.png)
CH (1) CH640140A5 (US20110009641A1-20110113-C00185.png)
DE (1) DE2751717A1 (US20110009641A1-20110113-C00185.png)
DK (1) DK529377A (US20110009641A1-20110113-C00185.png)
ES (1) ES464681A1 (US20110009641A1-20110113-C00185.png)
FI (1) FI60022C (US20110009641A1-20110113-C00185.png)
FR (1) FR2372841A1 (US20110009641A1-20110113-C00185.png)
GB (1) GB1558943A (US20110009641A1-20110113-C00185.png)
GR (1) GR64099B (US20110009641A1-20110113-C00185.png)
HK (1) HK50581A (US20110009641A1-20110113-C00185.png)
IE (1) IE46104B1 (US20110009641A1-20110113-C00185.png)
IT (1) IT1092178B (US20110009641A1-20110113-C00185.png)
NL (1) NL7713362A (US20110009641A1-20110113-C00185.png)
NZ (1) NZ185846A (US20110009641A1-20110113-C00185.png)
PT (1) PT67350B (US20110009641A1-20110113-C00185.png)
SE (1) SE443294B (US20110009641A1-20110113-C00185.png)
YU (1) YU41084B (US20110009641A1-20110113-C00185.png)
ZA (1) ZA777185B (US20110009641A1-20110113-C00185.png)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
JPS5625114A (en) * 1979-08-07 1981-03-10 Green Cross Corp:The Preparation of human gamma globulin
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
JPS57203017A (en) * 1981-06-09 1982-12-13 Fujirebio Inc Purifying method of immunoglobulin
JPS5821623A (ja) * 1981-07-28 1983-02-08 Tetsuzo Sugizaki 抗原抗体複合体沈着疾患治療剤
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
JPS5855432A (ja) * 1981-09-29 1983-04-01 Fujirebio Inc 静脈注射用免疫グロブリンの製法
ATE17654T1 (de) * 1981-10-29 1986-02-15 Green Cross Corp Verfahren zur herstellung von intravenoesem injizierbarem immunoglobulin.
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
JPS58180433A (ja) * 1982-04-16 1983-10-21 Fujirebio Inc 免疫グロブリンから抗補体作用物質の除去法
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
JPS59157017A (ja) * 1983-02-25 1984-09-06 Green Cross Corp:The 静脈投与用γ−グロブリン製剤
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4719290A (en) * 1983-09-02 1988-01-12 Armour Pharmaceutical Corporation Composition of intravenous immune globulin
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
DE3483784D1 (de) * 1984-07-07 1991-01-31 Woelm Pharma Gmbh & Co Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
GB8519848D0 (en) * 1985-08-07 1985-09-11 Schweiz Rotes Kreuz Treatment of chronic inflammatory disease
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
JPH0452190Y2 (US20110009641A1-20110113-C00185.png) * 1986-07-30 1992-12-08
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンa製剤の製造法
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
JPH07285609A (ja) * 1994-04-18 1995-10-31 Japan Steel & Tube Constr Co Ltd ごみ真空輸送装置の閉塞解除運転方法及びその装置
JP5525118B2 (ja) 2002-09-11 2014-06-18 中外製薬株式会社 タンパク質精製方法
TWI489994B (zh) 2008-03-17 2015-07-01 Baxter Healthcare Sa 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
JP5734985B2 (ja) 2009-09-17 2015-06-17 バクスター・ヘルスケヤー・ソシエテ・アノニムBaxter Healthcare SA ヒアルロニダーゼおよび免疫グロブリンの安定な共製剤およびそれらの使用方法
CA2941230C (en) 2014-03-11 2020-08-25 Green Cross Holdings Corporation Method for purifying immunoglobulin
CN106414476B (zh) 2014-03-11 2019-12-31 株式会社绿十字控股 用于纯化免疫球蛋白的方法
KR101657690B1 (ko) 2015-06-05 2016-09-19 주식회사 녹십자홀딩스 혈장 유래 b형 간염 사람 면역글로불린 제제의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520076A (en) * 1947-07-18 1950-08-22 John W Williams Process for separating and recovering globulins from blood plasmas
NL286954A (US20110009641A1-20110113-C00185.png) * 1962-01-03
SE348942B (US20110009641A1-20110113-C00185.png) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
ZA738779B (en) * 1972-11-27 1974-10-30 Baxter Laboratories Inc Production of gamma globulin
JPS49101516A (US20110009641A1-20110113-C00185.png) * 1973-01-13 1974-09-25
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin
US3808189A (en) * 1973-03-15 1974-04-30 American Cyanamid Co Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol
FR2267115B1 (US20110009641A1-20110113-C00185.png) * 1974-04-12 1977-11-10 Merieux Inst
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
JPS5193935A (US20110009641A1-20110113-C00185.png) * 1975-02-15 1976-08-18
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol

Also Published As

Publication number Publication date
PT67350A (en) 1977-12-01
ZA777185B (en) 1979-08-29
SE7713719L (sv) 1978-06-04
SE443294B (sv) 1986-02-24
US4124576A (en) 1978-11-07
IE46104B1 (en) 1983-02-23
CH640140A5 (de) 1983-12-30
YU276577A (en) 1983-01-21
FI60022B (fi) 1981-07-31
DE2751717A1 (de) 1978-07-13
JPS5372816A (en) 1978-06-28
NZ185846A (en) 1980-10-24
KR810001001B1 (ko) 1981-08-29
PT67350B (en) 1979-10-10
FR2372841A1 (fr) 1978-06-30
AR215037A1 (es) 1979-08-31
GB1558943A (en) 1980-01-09
GR64099B (en) 1980-01-22
YU41084B (en) 1986-12-31
FI773477A (fi) 1978-06-04
JPS6016407B2 (ja) 1985-04-25
IE46104L (en) 1978-06-03
CA1100872A (en) 1981-05-12
AT361119B (de) 1981-02-25
AU3119677A (en) 1979-06-07
HK50581A (en) 1981-10-30
IT1092178B (it) 1985-07-06
DE2751717C2 (US20110009641A1-20110113-C00185.png) 1991-01-24
FI60022C (fi) 1981-11-10
ATA833377A (de) 1980-07-15
DK529377A (da) 1978-06-04
AU516176B2 (en) 1981-05-21
NL7713362A (nl) 1978-06-06
ES464681A1 (es) 1978-09-01
BE861463A (fr) 1978-06-02

Similar Documents

Publication Publication Date Title
FR2372217B1 (US20110009641A1-20110113-C00185.png)
FR2374684B1 (US20110009641A1-20110113-C00185.png)
FR2353100B1 (US20110009641A1-20110113-C00185.png)
DE2654337C3 (US20110009641A1-20110113-C00185.png)
JPS52130383U (US20110009641A1-20110113-C00185.png)
DK135905C (US20110009641A1-20110113-C00185.png)
DK87076A (US20110009641A1-20110113-C00185.png)
DK380476A (US20110009641A1-20110113-C00185.png)
CS177789B1 (US20110009641A1-20110113-C00185.png)
CS178386B1 (US20110009641A1-20110113-C00185.png)
DD124862A1 (US20110009641A1-20110113-C00185.png)
DD127117A1 (US20110009641A1-20110113-C00185.png)
CH611653A5 (US20110009641A1-20110113-C00185.png)
CH611685A5 (US20110009641A1-20110113-C00185.png)
CH611753A5 (US20110009641A1-20110113-C00185.png)
CH611848A5 (US20110009641A1-20110113-C00185.png)
CH604036A5 (US20110009641A1-20110113-C00185.png)
CH612381A5 (US20110009641A1-20110113-C00185.png)
CH608515A5 (US20110009641A1-20110113-C00185.png)
CH613235A5 (US20110009641A1-20110113-C00185.png)
CH613333GA3 (US20110009641A1-20110113-C00185.png)
CH613574A5 (US20110009641A1-20110113-C00185.png)
CH614290A5 (US20110009641A1-20110113-C00185.png)
DD123585A6 (US20110009641A1-20110113-C00185.png)
CH611597A5 (US20110009641A1-20110113-C00185.png)

Legal Events

Date Code Title Description
ST Notification of lapse